Nuveen Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $481K | Sell |
314,275
-792,421
| -72% | -$1.21M | ﹤0.01% | 2999 |
|
|
2024
Q3 | $2.2M | Sell |
1,106,696
-73,532
| -6% | -$146K | ﹤0.01% | 2370 |
|
|
2024
Q2 | $4.13M | Buy |
1,180,228
+85,541
| +8% | +$299K | ﹤0.01% | 2049 |
|
|
2024
Q1 | $3.03M | Buy |
1,094,687
+1,002,935
| +1,093% | +$2.78M | ﹤0.01% | 2204 |
|
|
2023
Q4 | $156K | Hold |
91,752
| – | – | ﹤0.01% | 3245 |
|
|
2023
Q3 | $94.5K | Hold |
91,752
| – | – | ﹤0.01% | 3129 |
|
|
2023
Q2 | $106K | Sell |
91,752
-629,279
| -87% | -$730K | ﹤0.01% | 3146 |
|
|
2023
Q1 | $1.09M | Buy |
721,031
+436,516
| +153% | +$659K | ﹤0.01% | 2581 |
|
|
2022
Q4 | $712K | Sell |
284,515
-2,765
| -1% | -$6.92K | ﹤0.01% | 2803 |
|
|
2022
Q3 | $1.21M | Sell |
287,280
-639
| -0.2% | -$2.7K | ﹤0.01% | 2658 |
|
|
2022
Q2 | $804K | Sell |
287,919
-271,153
| -49% | -$757K | ﹤0.01% | 2888 |
|
|
2022
Q1 | $2.86M | Sell |
559,072
-161,797
| -22% | -$829K | ﹤0.01% | 2348 |
|
|
2021
Q4 | $6.1M | Sell |
720,869
-28,041
| -4% | -$237K | ﹤0.01% | 2007 |
|
|
2021
Q3 | $9.06M | Sell |
748,910
-75,403
| -9% | -$912K | ﹤0.01% | 1846 |
|
|
2021
Q2 | $12.8M | Buy |
824,313
+333,667
| +68% | +$5.18M | ﹤0.01% | 1698 |
|
|
2021
Q1 | $7.95M | Buy |
490,646
+46,111
| +10% | +$747K | ﹤0.01% | 1922 |
|
|
2020
Q4 | $9.41M | Sell |
444,535
-317,830
| -42% | -$6.73M | ﹤0.01% | 1741 |
|
|
2020
Q3 | $11.3M | Sell |
762,365
-121,985
| -14% | -$1.81M | ﹤0.01% | 1446 |
|
|
2020
Q2 | $13M | Buy |
884,350
+46,816
| +6% | +$689K | 0.01% | 1306 |
|
|
2020
Q1 | $9.83M | Buy |
837,534
+126,654
| +18% | +$1.49M | ﹤0.01% | 1300 |
|
|
2019
Q4 | $16.7M | Buy |
710,880
+323,639
| +84% | +$7.61M | 0.01% | 1272 |
|
|
2019
Q3 | $7.16M | Buy |
387,241
+1,594
| +0.4% | +$29.5K | ﹤0.01% | 1762 |
|
|
2019
Q2 | $7.17M | Buy |
+385,647
| New | +$7.17M | ﹤0.01% | 1796 |
|